|
Cubeddu, L X; Hoffmann, I S; Talmaciu, R K et al. (1991) Carbachol-phorbol ester interactions at muscarinic receptors modulating dopamine release from rabbit striatal slices. Neurosci Lett 131:245-8
|
|
Faggin, B M; Cubeddu, L X (1990) Rapid desensitization of dopamine release induced by neurotensin and neurotensin fragments. J Pharmacol Exp Ther 253:812-8
|
|
Bonnet, J J; Benmansour, S; Costentin, J et al. (1990) Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol. J Pharmacol Exp Ther 253:1206-14
|
|
Faggin, B M; Zubieta, J K; Rezvani, A H et al. (1990) Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate. J Pharmacol Exp Ther 252:817-25
|
|
Niedzwiecki, D M; Cubeddu, L X; Mailman, R B (1989) Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum. J Pharmacol Exp Ther 250:117-25
|
|
Talmaciu, R K; Hoffmann, I S; Cubeddu, L X (1989) Differential effects of phorbol ester on prefrontal cortex and striatal dopamine terminals: dependence on rate and duration of stimulation. J Pharmacol Exp Ther 251:1160-5
|
|
Niedzwiecki, D M; Cubeddu, L X; Mailman, R B (1989) Comparative anticholinergic properties of thioridazine, mesoridazine and sulforidazine. J Pharmacol Exp Ther 250:126-33
|
|
Diliberto, P A; Jeffs, R A; Cubeddu, L X (1989) Effects of low extracellular chloride on dopamine release and the dopamine transporter. J Pharmacol Exp Ther 248:644-53
|
|
Cubeddu, L X; Lovenberg, T W; Hoffman, I S et al. (1989) Phorbol esters and D2-dopamine receptors. J Pharmacol Exp Ther 251:687-93
|
|
Zubieta, J K; Cragoe Jr, E J; Cubeddu, L X (1988) Effects of amiloride and 5-(N,N-hexamethylene)amiloride on dopaminergic and cholinergic neurotransmission. J Pharmacol Exp Ther 247:88-95
|
Showing the most recent 10 out of 17 publications
